Your session is about to expire
← Back to Search
Donor milk for Breastfeeding (MGM Trial)
N/A
Waitlist Available
Led By Valerie Flaherman, MD, MPH
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week and 1 month after enrollment
Awards & highlights
Summary
This trial will compare banked donor milk to formula for breastfeeding late preterm infants born in San Francisco to assess growth and impacts on the type of bacteria in the baby's intestine.
Eligible Conditions
- Premature Baby
- Growth Delay
- Microbial Colonization
- Breastfeeding
- Breast Milk Substitute Intolerance
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week and 1 month after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week and 1 month after enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Bifidobacteria
Clostridium
Lactobacillus
+1 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Donor milkActive Control1 Intervention
Pasteurized donor breast milk
Group II: Preterm infant formulaPlacebo Group1 Intervention
Preterm formula determined by clinical practice
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,528 Previous Clinical Trials
15,242,584 Total Patients Enrolled
University of California, DavisOTHER
919 Previous Clinical Trials
4,720,844 Total Patients Enrolled
Valerie Flaherman, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco
5 Previous Clinical Trials
4,115 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger